Pathogenesis of Chronic Fatigue Syndrome, a Multisystem Hypothesis

References

• Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Strauss SE, et al. Chronic Fatigue Syndrome: A working case definition. Ann Intern Med 1988; 108:387–389.
   PubMed Web of Science ®Google Scholar
• Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A, et al. The Chronic Fatigue Syndrome: A comprehensive approach to its definition and study. Ann Intern Med 1994; 121:953–960.
   PubMed Web of Science ®Google Scholar
• Bates DW, Schmitt W, Buchwald D, Ware NC, Lee J, Thoyer E, et al. Preva-lence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med 1993; 153: 2759–2765.
   PubMed Web of Science ®Google Scholar
• Buchwald D, Umali P, Umali J, Kith P, Pearlman T, Komaroff AL. Chronic fa-tigue and the chronic fatigue syndrome: Prevalence in a Pacific Northwest health care system. Ann Intern Med 1995; 123:81–88.
   PubMed Web of Science ®Google Scholar
• Levine P. What we know about Chronic Fatigue Syndrome and its relevance to the practicing physician. Am J Med 1998; 105:100S–103S.
   Google Scholar
• Komaroff AL, Buchwald DS. Chronic Fatigue Syndrome: An update. Annu Rev Med 1998; 49:1–13.
   PubMed Web of Science ®Google Scholar
• Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J ClM Microbiol 1990; 28:1403–1410.
   PubMed Web of Science ®Google Scholar
• Lloyd AR, Wakefield D, Boughton CR, Dwyer JK. Immunologic abnormalities in the chronic fatigue syndrome. Med J Aust 1989; 151:122–124.
   PubMed Web of Science ®Google Scholar
• Caligiuri M, Murry C, Buchwald D, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987; 139:3306–3313.
   PubMed Web of Science ®Google Scholar
• Eby N, Grufferman S, Huang M, et al. Natural killer cell activity in the chronic fatigue-immune dysfunction syndrome. In: Ades EW, Lopez C, editors Natural Killer Cells and Host Defens Basel: Karger, 1988:141–145.
   Google Scholar
• Maher K. Flow cytometric measurements of perforM and natural killer cell ac-tivity poster communication. American Association for Chronic Fatigue Syndrome Fifth International Conference, Seattle, January 2001.
   Google Scholar
• Chao CC, Janoff EN, Hu SX, et al. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 1991; 3:292–296.
   PubMed Web of Science ®Google Scholar
• Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The patho-physiologic roles of interleukin-6 in human disease. Ann Intern Med 1998; 128:127–137.
   PubMed Web of Science ®Google Scholar
• Hurwitz BE, Brownely KA, Fletcher MA, Klimas NG. Chronic fatigue syn-drome: Evidence supporting the hypothesis of a behaviorally-activated neuromod-ulator of fatigue. JCFS 2000; 6:45–63.
   Google Scholar
• Aoki T, Miyakoshi H, Usuda Y, Herberman RB. Low NK syndrome and its re-lationship to chronic fatigue syndrome. Clin Immunol Immunopathol 1993; 69:253–265.
   PubMedGoogle Scholar
• MacDonald KL, Osterholm MT, LeDell KH, White KE, Schenck CH, Chao CC. A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am J Med 1996; 100:549–553.
   Google Scholar
• Buchwald D, Herrell R, Ashton S, et al. A twin study of Chronic Fatigue. Psy-chosomatic Medicine 2001; 63:936–943.
   PubMed Web of Science ®Google Scholar
• Sigal LH. Summary of the first 100 patients seen at a Lyme disease referral cen-ter. Am J Med 1990; 88:577–581.
   PubMed Web of Science ®Google Scholar
• Salit IE. Precipitating factors for the chronic fatigue syndrome. J Psychiat 1997; 31:59–65.
   Google Scholar
• Scott LV, Medbak S, Dinan TG. Blunted adrenocorticotropin and cortisol re-sponses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand 1998; 97:450–457.
   Google Scholar
• De Becker P, De Meirler K, Joos E, et al. Attenuated DHEA response to i.v. ACTH injection in patients with chronic fatigue syndrome. Poster communication. First World Congress on Chronic Fatigue Syndrome and Related Disorders, Brussels, 1995.
   Google Scholar
• Kellner M, Wiedmann K, Holsboer F. Atrial natriuretic factor inhibits the CRH- stimulated secretion of ACTH and cortisol in man. Life Sci 1992; 50:1835–1842.
   Google Scholar
• Demitrack MA. Neuroendocrine correlates of chronic fatigue syndrome: A brief review. J Psychiatr Res 1997; 31:69–82.
   PubMed Web of Science ®Google Scholar
• Sutton RE, Koob GF, LeMoal M, Rivier J, Vale W. Corticotropin-releasing fac-tor produces behavioral activation in rats. Nature 1982; 297:331–333.
   Google Scholar
• Scott LV, Dinan TG. Urinary free cortisol excretion in chronic fatigue syn-drome, major depression and in healthy volunteers. J Affective Dis 1998; 47:49–54.
   PubMed Web of Science ®Google Scholar
• Joyce E, Blumenthal S, Wessely S. Memory, attention, and executive function in chronic fatigue syndrome. J Neurol Neurosurg Psychiat 1996; 60:495–503.
   PubMed Web of Science ®Google Scholar
• Freeman R, Komaroff A. Does the chronic fatigue syndrome involve the auto-nomic nervous system? Am J Med 1997; 102:357–364.
   PubMed Web of Science ®Google Scholar
• Schondorf R, Freeman R. The importance of orthostatic intolerance in the chronic fatigue syndrome. Am J Med Sci 1999; 317:117–123.
   PubMed Web of Science ®Google Scholar
• Manyari DE, Rose S, Tyberg JV, Sheldon RS. Abnormal reflex venous function in patients with neruomediated syncope. J Am Coll Cardiol 1996; 27:1730–1735.
   PubMed Web of Science ®Google Scholar
• Leese G, Chattington P, Fraser W, et al. Short-term night-shift work mimics the pituitary-adrenal dysfunction in chronic fatigue syndrome. J Clin Endocrinol Metab 1996; 81:1867–1870.
   PubMed Web of Science ®Google Scholar
• Holsboer F, Von Bardeleben U, Gerken A, Stall GK, Muller OA. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med 1984; 311:1127.
   PubMed Web of Science ®Google Scholar
• Johnson SK, DeLuca J, Fiedler N, Natelson BH. Cognitive functioning of pa-tients with chronic fatigue syndrome. CIM Infect Dis 1994; 18:S84–S85.
   PubMed Web of Science ®Google Scholar
• Marcel B, Komaroff AL, Fagioli LR, Kornish RJ, Albert MS. Cognitive deficits in patients with chronic fatigue syndrome. Biol Psychiatry 1996; 40:535–541.
   Google Scholar
• Michiels V, Cluydts R, Fischler B, Hoffmann G, Le Bon O, De Meirleir K. Cog-nitive functioning in patients with chronic fatigue syndrome. J CIM Exp Neuropsychol 1996; 18:666–677.
   Google Scholar
• DeLuca J, Johnson SK, Beldowicz D, Natelson BH. Neuropsychological im-pairments in chronic fatigue syndrome, multiple sclerosis and depression. J Neurol Neurosurg Psychiat 1995; 58:38–43.
   PubMed Web of Science ®Google Scholar
• Lange G, Wang S, DeLuca J, Natelson B. Neuroimaging in chronic fatigue syn-drome. Am J Med 1998; 105:50S–53S.
   Google Scholar
• Glaser R, Kiecolt-Glaser JK. Stress-associated immune modulation: Relevance to viral infections and chronic fatigue syndrome. Am J Med 1998; 105:35S–42S.
   Google Scholar
• Peterson DL. Chair Section Role of the Brain in the Pathogenesis of Medically Unexplained Symptoms 2003 6th International AACFS Conference on Chronic Fa-tigue Syndrome, Fibromyalgia and related illnesses.
   Google Scholar
• Evangard B, Schacterle RS, Komaroff AL. Chronic fatigue syndrome: New in-sights and old ignorance. J Intern Med 1999; 246:455–469.
   Google Scholar
• Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 1993; 269:1812–1816.
   PubMed Web of Science ®Google Scholar
• Coyle PK, Drupp LB, Doscher C, Amin K. Borrelia burgdoiferi reactivity in patients with severe persistent fatigue who are from a region in which Lyme disease is endemic. CIM Infect Dis 1994; 18:S24–S27.
   PubMed Web of Science ®Google Scholar
• Marmion BP, Shannon M, Maddocks I, Storm P, Pentitla I. Protracted debility and fatigue after acute Q fever. Lancet 1996; 347:977–978.
   Google Scholar
• Buchwald D, Cheney PR, Peterson D, et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 1985; 102:7–16.
   PubMed Web of Science ®Google Scholar
• Yalcin S, Kuratsune H, Yamaguchi K, Kitani T, Uamanishi K. Prevalence of human herpesvirus 6 variants A and B in patients with chronic fatigue syndrome. Microbiol Immunol 1994; 38:587–590.
   Google Scholar
• Patnaik M, Komaroff AL, Conley E, Ojo-Amaize EA, Peter JB. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome. J Infect Dis 1995; 172:1364–1367.
   Google Scholar
• Zorezenon M, Rukh G, Botta GA, Colle R, Barsanti LA, Ceccherini-Nelli L. Active HHV-6 infection in chronic fatigue syndrome patients from Italy: New data. J Infect Dis 1996; 2:3–12.
   Google Scholar
• Nakaya T, Takahashi H, Nakamura Y, et al. Demonstration of Boma disease vi-rus RNA in peripheral blood mononuclear cells derived from Japanese patients with chronic fatigue syndrome. FEBS Lett 1996; 378:145–149.
   PubMed Web of Science ®Google Scholar
• Kitani T, Kuratsune H, Fuke I, et al. Possible correlation between Boma disease virus infection and Japanese patients with chronic fatigue syndrome. Micro biol Immunol 1996; 40:459–462.
   PubMed Web of Science ®Google Scholar
• Evengard B, Briese T, Lindh G, Lee S, Lipkin WI. No evidence of Boma dis-ease virus in Swedish patients with chronic fatigue syndrome. J Neurovirology 1999; 5:495–499.
   Google Scholar
• Pall ML. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med Hypoth 2000; 54:115–125.
   PubMed Web of Science ®Google Scholar
• Chao CC, Lokensgard JR, Sheng WS, Hu S, Peterson PK. IL-induced iNOS ex-pression in human astrocytes via NK-a. Neuroreport 1997; 8:3163–3166.
   Google Scholar
• Pahan K, Sheikh FG, Namboodiri AM, Singh L. N-acetyl cysteine inhibits in-duction of NO production by endotoxin or cytokine stimulated rat peritoneal macro-phages, C6 glial cells and astrocytes. FreeRadic Biol Med 1998; 24:39–48.
   PubMed Web of Science ®Google Scholar
• Holzmann A. Nitric oxide and sepsis. Respir Care CIMN Am 1997; 3:537–550.
   PubMedGoogle Scholar
• Beckman JS, Crow JP. Pathological implications of nitric oxide, superoxide and peroxynitite formation. Biochem Soc Trans 1993; 21:330–334.
   PubMed Web of Science ®Google Scholar
• Radi R, Rodriguez M, Castro L, Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994; 308:89–95.
   PubMed Web of Science ®Google Scholar
• Schedlowski M, Jacobs R, Stratmann G, et al. Changes in natural killer cells during acute psychological stress. J CIM Immunol 1993; 13:119–126.
   Web of Science ®Google Scholar
• Siber WJ, Rodin J, Larson L, et al. Modulation of human natural killer cell ac-tivity by exposure to uncontrollable stress. Brain Behav Immun 1992; 6:141–156.
   PubMed Web of Science ®Google Scholar
• Stevens A, Kloter I, Roggendorf W. Inflammatory infiltrates and natural killer cell presence in human brain tumors. Cancer 1988; 61:738–743.
   Google Scholar
• Whiteside T, Friberg, D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 1998; 105:27S–34S.
   Google Scholar
• Ottaway CA, Husband AJ. Central nervous system influences on lymphocyte migration. Brain Behav Immun 1992; 6:97–116.
   PubMed Web of Science ®Google Scholar
• Breviario F, Proserpio P, Bertocchi F, Lampugnani MG, Mantovani A, Dejana E. Interleukin-1 stimulates prostacyclin production by cultured human endothelial cells by increasing arachidonic acid mobilization and conversion. Arteriosclerosis 1990; 10:129–134.
   PubMedGoogle Scholar
• Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992; 6:2591–2599.
   PubMed Web of Science ®Google Scholar
• Dejana E, Breviario F, Erroi A, et al. Modulation of endothelial cell functions by different molecular species of interleukin 1. Blood 1987; 69:695–699.
   PubMed Web of Science ®Google Scholar
• Gulick T, Ching MK, Pieper SJ. Interleukin-I and tumor necrosis factor inhibits cardiac myocyte beta-adrenergic responses. Proc Nall Acad Sci USA 1989; 86:6753–6757.
   Google Scholar
• Krupp LB, Jandorf L, Coyle PK, Mendelson WB. Sleep disturbance in chronic fatigue syndrome. J Psychosom Res 1993; 37:325–331.
   PubMed Web of Science ®Google Scholar
• Moldofsky H. Sleep and fibrositis syndrome. Rheumatic disease of NA (Edited by Bennet RM, Goldenberg DL) 1989; 15:92–103.
   Google Scholar
• Mullington JM, Hinze-Selch D, Pollmacher T. Mediators of inflammation and their interaction with sleep. Relevance for chronic fatigue syndrome and related condi-tions. Annals IVY Acael Sc 2001; 933:201–210.
   Google Scholar
• Borish L, Schmaling K, Di Clementi JD, et al. Chronic fatigue syndrome: Iden-tification of distinct subgroups on the basis of allergy and psychological variables. J Allergy Clin Immunol 1998; 102:222–230.
   PubMed Web of Science ®Google Scholar
• Rowe PC, Clakins H. Neurally mediated hypotension and chronic fatigue syn-drome. Am J Med 1998; 105:15S–21S.
   Google Scholar
• Demitrak MA, Dale JK, Strauss SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J ClM Endocrinol Metab 1991; 73:1223–1234.
   Google Scholar
• Ehlers CL, Kupfer DJ. Hypothalamic peptide modulation of sleep EEG in de-pression: A further application of the S-process hypothesis. Biol Psychiatry 1987; 22:513–517.
   PubMed Web of Science ®Google Scholar
• Steiger A, Guldner J, Knisatschek H, et al. Effects of growth-hormone releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male con-trols. Neuroendocrinology 1992; 56:566–573.
   PubMed Web of Science ®Google Scholar
• Marshall PS, Forstot M, Callies A, Peterson P, Schenck CH. Cognitive slowing and working memory difficulties in chronic fatigue. Psychosomatic Medicine 1997; 59:58–66.
   Google Scholar
• DeLuca J, Johnson SK, Ellis SP, Natelson BH. Cognitive functioning is im-paired in patients with chronic fatigue syndrome devoid of psychiatric disease. J Neurol Neurosurg Psychiatry 1997; 62:151–155.
   PubMed Web of Science ®Google Scholar
• Suhadolnik RJ, Peterson DL, Reichenbach NL, et al. Chronic fatigue syndrome is distinct from depressed and healthy controls: Biochemical and clinical differences. Presentation at the biannual 2003AACFS International Conference on CFS.
   Google Scholar
• Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. Q J Med 1995; 88:767–773.
   Google Scholar
• Tirelli U, Chierchetti F, Tavio M, et al. Brain Positron Emission Tomography (PET) in chronic fatigue syndrome: Preliminary data. Am J Med 1998; 105:54S.
   PubMedGoogle Scholar